Sarah T. Connolly’s AbbVie ABBV Stock Holding History

Sarah T. Connolly’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,515	Closed	-$971K	–	6
2023 Q3	$971K	Sell	6,515 -75	-1%	-$11K	0.64%	53
2023 Q2	$888K	Hold	6,590	–	–	0.54%	58
2023 Q1	$1.05M	Hold	6,590	–	–	0.67%	56
2022 Q4	$1.07M	Sell	6,590 -50	-0.8%	-$7.67K	0.72%	53
2022 Q3	$891K	Hold	6,640	–	–	0.65%	59
2022 Q2	$1.02M	Hold	6,640	–	–	0.69%	56
2022 Q1	$1.08M	Hold	6,640	–	–	0.63%	53
2021 Q4	$899K	Buy	6,640 +125	+2%	+$14.8K	0.5%	60
2021 Q3	$703K	Buy	6,515 +50	+0.8%	+$5.71K	0.58%	58
2021 Q2	$728K	Sell	6,465 -50	-0.8%	-$5.63K	0.59%	56
2021 Q1	$705K	Sell	6,515 -25	-0.4%	-$2.67K	0.63%	54
2020 Q4	$701K	Buy	+6,540	New	+$628K	0.64%	54

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sarah T. Connolly's ABBV Position: Q4 2023 in Review

Sarah T. Connolly sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 6,515 shares — an estimated $971K sold.

Sarah T. Connolly first reported a position in ABBV in Q4 2020 and held it in 12 quarters. The position peaked at $1.08M in Q1 2022. 3,323 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

Sarah T. Connolly reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
Sarah T. Connolly sold 6,515 AbbVie shares in Q4 2023, an estimated $971K.
Sarah T. Connolly first reported a position in AbbVie in Q4 2020 and held it in 12 quarters.
Sarah T. Connolly's AbbVie position peaked at $1.08M in Q1 2022.
3,323 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Sarah T. Connolly's 13F filing for Q4 2023, filed 9 Feb 2024.